Pharma IQ caught up with Dr. Ole Østerberg, Clinical Research Scientist at NeuroSearch, ahead of the Bioequivalence and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,250 news
and
4,718 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Ian Anderson Director, External Networks, M&S Business Unit Norgine, spoke to Pharma IQ about the evolution of the...
Wall Street pored over new trial results for Amgen's anemia drug Aranesp on Aug. 26
Our nation's economy is in a recession. People are feeling the pain of job losses and working harder to make ends meet.
The ability to meet standards and regulatory approval is nowhere more important than in the pharmaceutical industry.
While technology has undoubtedly had an impact on the techniques pharmaceutical firms use to develop new drugs, the...
Vincent Andolina, VP Regulatory Affairs at GeneraMedix Inc identities the key risks facing the US generic drug industry
Finding a suitable contract manufacturing organisation (CMO) that meets your business needs, can be an expensive and...
Questions for the pharma industry? Ask Roger Perlmutter, EVP of R&D at Amgen
Significant advances in medical treatment worldwide have helped people live longer and better lives. Mortality and...
The giants of the pharmaceutical industry may have found their salvation in the wave of consolidation.
At the June 2010 Global Pharmaceutical Contract Manufacturing Convention in London, England, sterile fill/finish...
Students are questioning the financial relationships their professors have with drug companies.
he Biotech Industry Organization (BIO) this morning released a set of statistics that give a rather dire snapshot of...
Pressure on Henri A. Termeer, chief executive of American biotechnology giant Genzyme Corporation (NASDAQ: GENZ), has...
Carl Icahn attempted a hostile acquisition of the Hollywood studio Lionsgate Entertainment. According to a recent New...
Lilly is reportedly offering $6.1 billion for the maker of cancer drug Erbitux.
New research shows that studies suggesting drugs are ineffective are often not published by medical journals.
An osteoporosis drug boosts the biotech giant's prospects.
The credit crisis and resulting stock swoon may make it easier for drugmakers to acquire biotech companies.
Pascal Soriot, the man charged with integrating Roche Holding AG (SWX:ROG) and Genentech Inc. -- alongside former...
Biotechnology dealmakers are swooping into San Francisco this week for the industry's annual kickoff conference,...
The biotech industry employs hundreds of thousands of workers in the United States yet the health and safety of workers...
Nov. 2 (Bloomberg) -- Takeda Pharmaceutical Co., maker of the world’s best-selling diabetes drug, agreed to pay as much...
According to the National Venture Capital Assn. (NVCA), total venture capital investment for the first quarter of this...
Top Sources: Business of Biotechnology
- investorideas.com
- bioedgeconsulting.com
- Biotech Blog
- bloomberg.com
- News
- youtube.com
- contrarianprofits.com
- Forbes.com
- industry.bnet.com
- Health Beat
account